BackAngiodynamic Overview

Angiodynamic Cost of Revenue

Cost of Revenue analysis for ANGO.

Quarterly Cost of Revenue

$36.94M
11.46% YoY

As of Feb 28, 2026

Annual Cost of Revenue (TTM)

$148.62M
12.68% YoY

Trailing 12 months ending Feb 28, 2026

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)